The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection
Abstract
We sought to investigate alterations in quorum-sensing signal molecule N -acyl homoserine lactone secretion and in the release of Pseudomonas aeruginosa virulence factors, as well as the in vivo antimicrobial activity of bismuth-ethanedithiol incorporated into a liposome-loaded tobramycin formulation (LipoBiEDT-TOB) administered to rats chronically infected with P. aeruginosa . The quorum-sensing signal molecule N -acyl homoserine lactone was monitored by using a biosensor organism. P. aeruginosa virulence factors were assessed spectrophotometrically. An agar beads model of chronic Pseudomonas lung infection in rats was used to evaluate the efficacy of the liposomal formulation in the reduction of bacterial count. The levels of active tobramycin in the lungs and the kidneys were evaluated by microbiological assay. LipoBiEDT-TOB was effective in disrupting both quorum-sensing signal molecules N -3-oxo-dodeccanoylhomoserine lactone and N -butanoylhomoserine lactone, as well as significantly ( P < 0.05) reducing lipase, chitinase, and protease production. At 24 h after 3 treatments, the CFU counts in lungs of animals treated with LipoBiEDT-TOB were of 3 log 10 CFU/lung, comparated to 7.4 and 4.7 log 10 CFU/lung, respectively, in untreated lungs and in lungs treated with free antibiotic. The antibiotic concentration after the last dose of LipoBiEDT-TOB was 25.1 μg/lung, while no tobramycin was detected in the kidneys. As for the free antibiotic, we found 6.5 μg/kidney but could not detect any tobramycin in the lungs. Taken together, LipoBiEDT-TOB reduced the production of quorum-sensing molecules and virulence factors and could highly improve the management of chronic pulmonary infection in cystic fibrosis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the airway, liposomal formulations improve residence time, reduce epithelial toxicity, and enhance penetration of mucus-rich and matrix-rich regions.”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [203]
In the citing paper
“In a chronic Pseudomonas rat model, liposomal bismuth ethanedithiol lowered bacterial counts.”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [203]
In the citing paper
“Reviews support inhaled, NP enabled antibiotic strategies for difficult lung infections [203,204,205].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle formulations in pulmonary drug delivery
Bailey, M. M., & Berkland, C. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20140 · Cited by 302
Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery
Willis, L., Hayes, D., & Mansour, H. M. (2012) · Lung · doi:10.1007/s00408-011-9360-x · Cited by 148
Research works printed but not linked: 77
- 10.4187/aarc0443 · DOI
- 10.4187/aarc0446 · DOI
- 10.1097/MCP.0b013e32833f1d00 · DOI
- 10.1074/jbc.M505832200 · DOI · Paper page
- 10.1258/la.2007.06014e · DOI
- 10.1074/jbc.272.22.14037 · DOI · Paper page
- 10.1016/j.ijmm.2011.08.003 · DOI
- 10.1128/CMR.00068-09 · DOI · Paper page
- 10.1111/j.1469-0691.2011.03742.x · DOI
- 10.1002/ppul.10127 · DOI · Paper page
- 10.3389/fmicb.2011.00162 · DOI
- 10.1128/aem.60.6.1734-1738.1994 · DOI · Paper page
- 10.1097/QCO.0b013e32834748ff · DOI
- 10.1165/ajrcmb.19.2.2889 · DOI
- 10.1111/j.1365-2958.2005.05002.x · DOI · Paper page
- 10.1152/ajplung.00383.2001 · DOI · Paper page
- 10.1165/ajrcmb.19.6.3194 · DOI
- 10.1186/1471-2180-7-45 · DOI · Paper page
- 10.1128/JB.00007-07 · doi:10.1128/jb.00007-07
- 10.1557/mrs.2011.67 · DOI
- 10.1099/mic.0.028464-0 · doi:10.1099/mic.0.028464-0
- 10.1371/journal.pone.0010115 · DOI · Paper page
- 10.1093/emboj/cdg366 · DOI · Paper page
- 10.1128/JB.185.7.2066-2079.2003 · DOI · Paper page
- 10.1128/JB.183.24.7044-7052.2001 · DOI
- 10.1128/JB.186.10.2936-2945.2004 · DOI
- 10.1128/JB.00409-06 · DOI · Paper page
- 10.1099/mic.0.25967-0 · DOI
- 10.1073/pnas.92.20.9427 · DOI · Paper page
- 10.1042/BST0370863 · DOI
- 10.1002/ppul.20735 · DOI
- 10.4187/002013209790983241 · doi:10.4187/002013209790983241
- 10.1016/j.jcf.2009.08.004 · DOI
- 10.1016/j.jcf.2010.09.003 · doi:10.1016/j.jcf.2010.09.003
- 10.1056/NEJM199607183350307 · DOI · Paper page
- 10.1186/1471-2334-10-148 · DOI
- 10.1080/00313020400011300 · doi:10.1080/00313020400011300
- 10.1128/AAC.39.1.34 · DOI
- KhanW BernierSP KuchmaSL HammondJH HasanF O'TooleGA. 2010. Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide. Int. Microbiol. 13:207–212.
- 10.1097/MCP.0b013e32833eebfd · DOI
- 10.1128/JB.01655-07 · DOI · Paper page
- 10.1093/jac/43.5.659 · doi:10.1093/jac/43.5.659
- 10.1128/AAC.41.8.1697 · doi:10.1128/aac.41.8.1697
- 10.1093/jac/44.5.601 · doi:10.1093/jac/44.5.601
- 10.1007/BF01967072 · doi:10.1007/bf01967072
- 10.1093/jac/dkg471 · doi:10.1093/jac/dkg471
- 10.1165/ajrcmb.26.6.2001-00020oc · doi:10.1165/ajrcmb.26.6.2001-00020oc
- 10.1093/jac/dkp165 · DOI · Paper page
- 10.2174/092986709789712916 · DOI
- 10.1016/j.ijpharm.2008.03.008 · DOI
- 10.1016/j.ijpharm.2009.02.001 · doi:10.1016/j.ijpharm.2009.02.001
- 10.1016/j.mimet.2004.04.016 · DOI · Paper page
- 10.1099/0022-1317-51-12-1063 · DOI
- MillerJH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
- CashHA WoodsDE McCulloughB JohansonWGJr BassJA. 1979. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 119:453–459.
- 10.1128/AAC.38.5.1090 · DOI
- 10.1136/thx.2009.121657 · DOI · Paper page
- 10.1016/j.ijpharm.2007.11.035 · DOI
- 10.1093/jac/dkm289 · DOI
- 10.1111/j.1523-5378.2011.00857.x · DOI
- 10.1111/j.2042-7158.2011.01304.x · doi:10.1111/j.2042-7158.2011.01304.x
- 10.1158/1940-6207.CAPR-08-0237 · doi:10.1158/1940-6207.capr-08-0237
- 10.1080/10611860802201134 · DOI
- 10.1093/jac/dkg317 · DOI
- 10.1007/s11095-008-9755-4 · DOI · Paper page
- 10.1093/jac/dkn059 · DOI · Paper page
- 10.1016/j.ijpharm.2005.10.005 · DOI
- 10.1016/j.bbamem.2003.11.016 · DOI
- 10.3109/02652049309015314 · DOI
- HorrevortsAM DriessenOM MichelMF KerrebijnKF. 1988. Pharmacokinetics of antimicrobial drugs in cystic fibrosis: aminoglycoside antibiotics. Chest 94:120S–125S.
- 10.1128/AAC.40.3.665 · DOI
- 10.1016/S0006-2952(02)01346-1 · DOI · Paper page
- 10.1007/s12325-008-0105-2 · DOI
- 10.1186/cc2415 · DOI
- 10.1172/JCI116196 · DOI
- 10.1093/mutage/gep053 · DOI · Paper page
- 10.1136/thorax.57.9.759 · DOI · Paper page
Cited by
Lipid and polymer nanoparticles for drug delivery to bacterial biofilms
Forier, K., Raemdonck, K., De Smedt, S. C., Demeester, J., Coenye, T., & Braeckmans, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.055 · Cited by 464
Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections
Abed, N., & Couvreur, P. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.02.009 · Cited by 358
Nanoparticle approaches against bacterial infections
Gao, W., Thamphiwatana, S., Angsantikul, P., & Zhang, L. (2014) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1282 · Cited by 347
Eleraky, N. E., Allam, A., Hassan, S. B., & Omar, M. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020142 · Cited by 342
Ramasamy, M., & Lee, J. (2016) · BioMed Research International · doi:10.1155/2016/1851242 · Cited by 278
Metadata
- Authors
- Alhariri, M., & Omri, A.
- Affiliations
- Novel Drug and Vaccine Delivery Systems Facility, Department of Chemistry and Biochemistry, Laurentian University, Sudbury, ON, Canada
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-01
- Volume
- 57
- Issue
- 1
- Pages
- 569-578
- ISSN
- 0066-4804
- 1098-6596
- Cited by
- 53
- References
- 2
- Language
- en
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection. https://app.cochat.ai/papers/10.1128/aac.01634-12
- The paper
- Alhariri, M., & Omri, A. (2013). Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01634-12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.